ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 126 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,189 | -74.2% | 39,374 | 0.0% | 0.00% | – |
| Q2 2023 | $20,081 | +80224.0% | 39,374 | 0.0% | 0.00% | – |
| Q1 2023 | $25 | -3.8% | 39,374 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $26 | -100.0% | 39,374 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $68,000 | -83.5% | 39,374 | -88.1% | 0.00% | -90.9% |
| Q2 2022 | $411,000 | +90.3% | 331,401 | 0.0% | 0.01% | +120.0% |
| Q1 2022 | $216,000 | -40.2% | 331,401 | 0.0% | 0.01% | -16.7% |
| Q4 2021 | $361,000 | -40.1% | 331,401 | +0.0% | 0.01% | -40.0% |
| Q3 2021 | $603,000 | +337.0% | 331,280 | +535.9% | 0.01% | +233.3% |
| Q2 2021 | $138,000 | -79.9% | 52,097 | -80.8% | 0.00% | -84.2% |
| Q4 2020 | $685,000 | -20.9% | 271,773 | -20.9% | 0.02% | -50.0% |
| Q3 2020 | $866,000 | +346.4% | 343,526 | +479.5% | 0.04% | +280.0% |
| Q2 2020 | $194,000 | -37.6% | 59,281 | -53.3% | 0.01% | -64.3% |
| Q1 2020 | $311,000 | +371.2% | 126,840 | +689.9% | 0.03% | +1300.0% |
| Q4 2017 | $66,000 | -78.4% | 16,058 | -67.8% | 0.00% | -75.0% |
| Q3 2017 | $306,000 | -22.3% | 49,863 | -21.2% | 0.01% | -33.3% |
| Q2 2017 | $394,000 | +380.5% | 63,304 | +390.4% | 0.01% | +300.0% |
| Q1 2017 | $82,000 | -12.8% | 12,909 | -22.9% | 0.00% | +50.0% |
| Q3 2016 | $94,000 | -34.3% | 16,740 | -35.9% | 0.00% | -33.3% |
| Q2 2016 | $143,000 | -18.8% | 26,106 | +10.3% | 0.00% | -25.0% |
| Q1 2016 | $176,000 | -57.8% | 23,660 | -52.9% | 0.00% | -66.7% |
| Q4 2015 | $417,000 | -14.9% | 50,228 | -7.7% | 0.01% | -29.4% |
| Q3 2015 | $490,000 | +82.2% | 54,410 | +142.3% | 0.02% | +112.5% |
| Q2 2015 | $269,000 | -8.2% | 22,453 | -17.4% | 0.01% | -11.1% |
| Q1 2015 | $293,000 | +125.4% | 27,175 | +6.2% | 0.01% | +80.0% |
| Q4 2014 | $130,000 | +150.0% | 25,577 | +31.0% | 0.01% | +150.0% |
| Q3 2014 | $52,000 | -42.9% | 19,527 | -1.6% | 0.00% | -50.0% |
| Q1 2014 | $91,000 | -22.9% | 19,849 | -27.1% | 0.00% | -33.3% |
| Q4 2013 | $118,000 | +63.9% | 27,211 | +49.5% | 0.01% | +100.0% |
| Q3 2013 | $72,000 | +35.8% | 18,200 | -27.5% | 0.00% | -25.0% |
| Q2 2013 | $53,000 | – | 25,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 12,546,493 | $22,835,000 | 1.71% |
| MSD Partners, L.P. | 15,151,516 | $27,576,000 | 0.84% |
| MSD Partners, L.P. | 7,575,758 | $13,788,000 | 0.42% |
| CHIRON CAPITAL MANAGEMENT, LLC | 198,002 | $360,000 | 0.26% |
| Avidity Partners Management LP | 3,000,000 | $5,460,000 | 0.12% |
| Old West Investment Management, LLC | 211,513 | $384,000 | 0.10% |
| MAGNOLIA CAPITAL ADVISORS LLC | 103,239 | $188,000 | 0.07% |
| Virtus ETF Advisers LLC | 72,060 | $131,000 | 0.06% |
| ACT WEALTH MANAGEMENT, LLC | 34,454 | $91,000 | 0.06% |
| Allred Capital Management, LLC | 53,000 | $96,000 | 0.05% |